An interventional study of Rapid Maxillary Expansion Treatment in Posterior Crossbite, Upper Airway, sponsored by Izmir Katip Celebi University. Completed. Open to participants aged 12 Years to 14 Years. Per ClinicalTrials.gov, last updated 2020-08-27.
Sponsored by Izmir Katip Celebi University · Not applicable, Interventional, and Treatment
Rapid maxillary expansion (RME) is an orthodontic treatment based on the principle of opening the midpalatal suture with the effect of orthopedic forces. The aim of this randomized clinical study was to evaluate and compare the effects of tooth-borne, tooth-tissue borne, and bone-borne rapid maxillary expanders on nasal airway by using AR. The null hypothesis was that there is no difference for the effect on nasal airway between the appliances.
Introduction: The aim of this 3-arm parallel trial was to compare the effects of tooth-borne (Hyrax), tooth tissue-borne (KBME) and bone-borne (MIDME) rapid maxillary expansion (RME) appliances on nasal airway with acoustic rhinometry (AR).
Methods: Fourty-six 12- to 14-years-old patients with narrow maxilla were randomly allocated into 3 study groups according to the type of RME appliance: tooth-borne, tooth tissue-borne and bone-borne. Participants were recruited from the Department of Orthodontics, Faculty of Dentistry, Izmir Katip Celebi University, Turkey. During the RME treatment, the same protocol was applied to all patients and the expansion screws were activated twice a day (0.4 mm/day). Computer-generated randomization was used with group allocation concealed using opaque, sealed envelopes. The outcome assessor was blinded; however, it was not feasible to blind either operator or patients. The primary outcome of this study was the correction of posterior crossbite. Secondary outcomes included AR assessment of nasal airway dimensions as nasal volume, the minimal cross-sectional area (MCA) 1 and 2. AR measurements were obtained before treatment (T0), after active expansion (T1), and at 3 months-follow-up (T2). One-way analysis of variance (ANOVA) and a Bonferroni test was used for inter-group comparison and two-way ANOVA was used for intra-group evalaution.
457 studies on the registry are indexed under Malocclusion; 89 are open to participants now.
This study's enrollment of 46 is above the median of 36 across 371 interventional studies indexed under Malocclusion.
Browse Malocclusion studies →Izmir Katip Celebi University is the lead sponsor of 191 studies on the registry; 40 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Procedure: Rapid Maxillary Expansion Treatment
Procedure: Rapid Maxillary Expansion Treatment
Procedure: Rapid Maxillary Expansion Treatment
The patients were treated with KBME, Hyrax and MIDME maxillary expansion appliances, respectively. All expansion appliances containing a Hyrax expansion screw positioned parallel to the second premolars and were used to correct the posterior crossbite. In the MIDME group, two mini-screws with a diameter of 1.6 mm and a length of 10 mm are located on the right and left sides between the roots of the 2nd premolar and 1st molar teeth with 60-70° angle. KBME and Hyrax expansion appliances were cemented with glass ionomer cement and MIDME was cemented with using the light-cured composite. Same protocol was applied to all patients during RME treatment. Expansion screws in all groups were activated by two turns a day.
Correction of posterior crossbite
The palatal cusps of the maxillary posterior teeth approximated the lingual cusps of the mandibular posterior teeth.
Time frame: After active expansion (up to 3 weeks) (T1).
Increasing nasal cavity area-1
Increasing Minimum cross-sectional area1 (MCA1)
Time frame: At baseline (T0), after active expansion (up to 3 weeks) (T1) and after 3 months retention period (T2)
Increasing nasal cavity area-2
Minimum cross-sectional area2 (MCA2)
Time frame: At baseline (T0), after active expansion (up to 3 weeks) (T1) and after 3 months retention period (T2)
Increasing nasal cavity volume
Volume (Vol)
Time frame: At baseline (T0), after active expansion (up to 3 weeks) (T1) and after 3 months retention period (T2)
No study locations are listed for this record.
Plan to share: Undecided
This study is completed, as verified in Aug 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Izmir Katip Celebi University